Patent ID: 7300655

Claim:
A method of treating a cancer cell in a subject comprising: (i) obtaining a composition comprising a humanized anti-alpha fetoprotein (anti-AFP) antibody, antibody fragment or fusion protein in a pharmaceutically suitable excipient, said antibody, antibody fragment or fusion protein comprising the heavy chain CDR1 (SYVIH, SEQ ID NO:4), CDR2 (YIHPYNGGTKYNEKFKG, SEQ ID NO:5) and CDR3 (SGGGDPFAY, SEQ ID NO:6) and the light chain CDR1 (KASQDINKYIG, SEQ ID NO:1), CDR2 (YTSALLP, SEQ ID NO:2) and CDR3 (LQYDDLWT, SEQ ID NO:3) sequences of the Immu31 antibody; and (ii) administering a therapeutically effective amount of said composition to a human subject.